Dow Jones Top Company Headlines at 7 AM ET: Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera | Merck ...
Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera
The Wegovy and Ozempic maker's offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed obesity-drug developer.
----
Merck Profit Rises on Strong Keytruda Demand
Merck reported higher third-quarter profit and boosted its full-year outlook, as demand for its flagship Keytruda cancer drug continues to rise.
----
Cigna Posts Higher Profit, Revenue as Evernorth Business Continues to Grow
Cigna Group logged higher profit and revenue in the third quarter, boosted by continued strength in its pharmacy-benefit business Evernorth.
----
Kimberly-Clark Profit Falls, Organic Sales Rise
Kimberly-Clark's third-quarter profit fell 51% as a result of divestitures, business exits and recent tariffs, although sales ticked up slightly.
----
Shell Renews $3.5 Billion Quarterly Buyback Program as Earnings Rise
Adjusted earnings rose to $5.43 billion, boosted by improved trading performance and higher margins.
----
Meta Still Has a Lot to Prove in AI Race
The Facebook parent's business model sparks more questions about the eventual payoff than rivals such as Google and Microsoft.
----
YouTube TV Flexes Muscles Again in Showdown With Disney
The Google-owned pay-TV service has amassed considerable clout with its growing base of about 10 million subscribers. Its negotiations with Disney could test how much power it really holds.
----
TotalEnergies Posts Jump in Profit
Net profit for the quarter rose to $3.68 billion, lifted by higher production and stronger refining profit.
----
Carlsberg Beer Volumes Fall on Tough Consumer Sentiment
The brewer reported a 3% drop in organic volumes but maintained its full-year guidance.
----
Standard Chartered Profit Rises on Stronger Wealth Business
The London-based bank upgraded its operating income and return guidance, as strength in its wealth business boosted net profit.
----
AB InBev Launches $6 Billion Buyback Despite Continuing Beer Sales Decline
The Budweiser brewer cited solid underlying results for the buyback, but said weak performance in China weighed on beer sales volumes.
----
Volkswagen Backs Guidance But Cautions on Chip Supply
The German automaker said Thursday that chip shortages haven't yet had an impact on output at its German factories, but noted the situation is dynamic.
----
ING Launches $1.28 Billion Buyback as Earning Beat Expectations
The lender reported a smaller-than-expected drop in net profit, while raising its full-year total income guidance.
----
Credit Agricole Profit Rises on Customer Activity
Net profit rose 10% as sustained activity across the French lender's business lines and higher customer numbers supported income.
----
Deutsche Lufthansa Sees Demand Stabilizing as Costs Eat Into Net Profit
Lufthansa said fourth quarter bookings to date pointed to more stable demand for all traffic regions including its North Atlantic and European routes.
----
BBVA's Profit Suffers from Currency Hit Despite Strong Loan Growth
Net profit was down 3.7% even as gross income rose on growth in net interest income, and higher commissions and fees.
----
Societe Generale Net Profit Rose in Third Quarter
Societe Generale's third-quarter net profit rose as the bank continued to benefit from a rebound in its domestic retail-banking operations.
----
Hyundai Earnings Fall on U.S. Tariffs; Relief in Sight
South Korea's largest carmaker posted weaker earnings in the third quarter, dented by U.S. tariffs.
----
Lynas Rare Earths to Closely Manage Output, Sales Amid China Uncertainty
Lynas Rare Earths will closely manage production rates and sales until there is more clarity on Chinese export controls on rare earths and related technologies.
(END) Dow Jones Newswires
October 30, 2025 07:15 ET (11:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
This Once-Hot AI Stock Now Looks Deeply Undervalued
The 10 Best Companies to Invest in Now
3 of the Best Dividend Stocks to Own
